I would hope a couple of other questions will be answered.
In a Boardroom Radio Interview the following was said on 12 May 2014
"We are also actively working with our second trial site at the University of California,
San Diego, to bring it online to identify further subjects that meet these criteria."
"PF: We’ll be monitoring the activity at Duke, and at our second site, UCSD, as they
screen patients for TT-034 trial eligibility, and we will of course keep the market
updated as we make material progress around dosing and trial sites."
To date have seen no updates or progress, why? Is there an issue?
http://clinicaltrials.gov/ct2/show/NCT01899092 shows it "Not recruiting yet" almost 7 months since approval.
Do we have a second candidate?
